期刊文献+

美托洛尔治疗冠心病的临床分析

下载PDF
导出
摘要 目的探讨美托洛尔治疗冠心病的临床效果。方法:选取我院2014年6月-2015年2月收治的82例冠心病患者为研究对象,随机均分为对照组和观察组,对照组采用常规治疗,观察组在常规治疗的同时采用美托洛尔治疗,观察两组患者的临床治疗效果。结果:观察组患者的临床治疗总有效率为97.56%明显高于对照组患者的治疗总有效率78.45%,两组患者的总有效率差异显著,差异具有统计学意义(P〈0.05)。结论:采用美托洛尔治疗冠心病,可以有效改善冠心病的临床症状,缓解患者出现心绞痛,值得在临床上广泛推广使用。 Objective To investigate the clinical effect of metoprolol in the treatment of coronary heart disease. Methods: Selected in our hospital in June 2014and 2015 February were 82 cases of patients with coronary heart disease (CHD) as the research object, were randomly divided to observation group and controlgroup. The control group with conventional therapy, the observation group in the conventional therapy and the use of metoprolol in the treatment, to observeclinical therapeutic effect of two groups of patients. Results: Clinical observation of treatment of patients with total effective rate was 97.56% was significantlyhigher than that of the control group, the treatment efficiency was 78.45%, two groups of patients with total efficiency has significant difference, the difference isstatistically significant (P 〈 0.05). Conclusion: The use of metoprolol in the treatment of coronary heart disease (CHD) can effectively improve the coronary heartdisease clinical symptoms and remission in patients with angina pectoris, it !s widely used in clinic.
作者 张天峰
机构地区 洛南县医院
出处 《世界中医药》 CAS 2016年第B03期424-424,共1页 World Chinese Medicine
关键词 美托洛尔 冠心病 临床疗效 Mei TORO M coronary heart disease clinical curative effect
  • 相关文献

参考文献4

二级参考文献52

  • 1焦溥蕙.冠心病的预防策略[J].中国老年学杂志,2005,25(7):860-863. 被引量:30
  • 2黄浙勇,江时森,吕磊.早发冠心病患者危险因素和冠状动脉病变的性别差异[J].中国慢性病预防与控制,2006,14(6):395-397. 被引量:4
  • 3楚玉荣,楚智慧,朱颖钊.ApoE基因多态性与早发冠心病关系的研究[J].现代生物医学进展,2007,7(2):244-246. 被引量:5
  • 4中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5230
  • 5Sivapalaratnam S, Boekholdt SM, Trip MD, et al. Family history of premature coronary heart disease and risk prediction in the EPIC - Norfolk prospective population study [J]. Heart, 2010, 96 (24) : 1085 - 1089.
  • 6Mills EJ, Wu P, Chong G, et al. Efficacy and safety of statin treatment for cardiovascular disease: a network meta - analysis of 170 255 patients from76 randomized trials [J]. QJM, 2011, 104 (02) : 174 - 178.
  • 7Afilalo J, Majdan AA, Eisenberg MJ. Intensive statin therapy in acute coronary syndromes and stable coronary heart disease: a comparative meta - analysis of randomised controlled trials [ J ]. Heart, 2007, 93 (08) : 914 -921.
  • 8Ballantyne C, Arroll B, Shepherd J. Lipids and CVD management: towards a global consensus [J]. Eur Heart J, 2005, 26 (21) : 2224 -2231.
  • 9Koh KK. Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability [J]. Cardiovase Res, 2000, 47(04) : 648 -657.
  • 10Chen LJ, Chester M, Kaski JC. Clinical factors and angiographic features associated with premature coronary artery disease [ J ]. Chest, 1995, 108 (2): 364-369.

共引文献279

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部